5 ms·
There’s got to be a large market for that given the entire elderly population is offered a flu shot every year. Doing that as a one off would be a huge cost sav
by jbjbjbjb 5y ago
There’s got to be a large market for that given the entire elderly population is offered a flu shot every year. Doing that as a one off would be a huge cost saving.
- lazide 5y agoNot sure it would pay for itself even in 100 years if you use that metric. $20 (likely current retail cost of a flu shot) x the 46 million older adults in the US is a hair less than a billion a year. Making 131 or so effective flu vaccines and getting them through the process with the prior known and effective process? (including all the failed attempts) Hopefully we’d get some economies of scale, estimates [https://www.passporthealthusa.com/2018/02/how-much-does-it-cost-to-develop-a-new-vaccine/ https://www.passporthealthusa.com/2018/02/how-much-does-it-c...] I found had it between 500m to 2.5billion and a decade each. So 65billion to 327billion. So between 65 to 327 years for positive ROI if that was your metric. If you’re talking public good, it would be immeasurable for us and the world though, no question, and on the high end that’s less than a third [https://www.google.com/amp/s/www.bbc.co.uk/news/world-47391821.amp https://www.google.com/amp/s/www.bbc.co.uk/news/world-473918...] of what we’ve spent in Afghanistan alone.
- jbjbjbjb 5y agoI believe they’d make one shot that would handle 131 flus.
- lazide 5y agoThat would be ideal - we also have no evidence that is possible at all, or desirable with immune system behavior/interactions. We'd need try to find out, which I personally think would be way better for everyone involved than many other things we spend money on. So take that as my vote for trying?